These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effects of a synthetic ganglion blocking agent derived from thiophanium (arfonad) on visceral circulation]. BENELLI C, ROUGIER G. C R Seances Soc Biol Fil; 1956 Nov 18; 150(6):1191-2. PubMed ID: 13383932 [No Abstract] [Full Text] [Related]
4. [Preliminary report on arfonad]. DECHENE JP, MASSON V, AUM EN. Laval Med; 1955 Dec 18; 20(10):1333-43. PubMed ID: 13308173 [No Abstract] [Full Text] [Related]
8. [Our findings on arfonad, based on 50 cases]. CALLEWAERT G. Belg Tijdschr Geneesk; 1955 Nov 15; 11(22):1091-101. PubMed ID: 13283958 [No Abstract] [Full Text] [Related]
9. Observations on the hemodynamic properties of a thiophanium derivative, Ro 2-2222 (arfonad), in human subjects. ASSALI NS, DOUGLASS RA, SUYEMOTO R. Circulation; 1953 Jul 15; 8(1):62-9. PubMed ID: 13059864 [No Abstract] [Full Text] [Related]